Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill A Ohar

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|December 16, 2024
COPD and Immune Checkpoint Inhibitors for Cancer: A Literature ReviewThomas W Lycan, Dustin L Norton, Jill A Ohar
Pulmonary Therapy|August 19, 2020
In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®Jill A Ohar, Andrea Bauer, Sanjay Sharma, et al.
Annals of the American Thoracic Society|March 15, 2016
Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United StatesSuchit Kumbhare, Roy Pleasants, Jill A Ohar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2020
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized GlycopyrrolateJill A Ohar, Ayca Ozol-Godfrey, Thomas Goodin, et al.
Life (Basel, Switzerland)|November 27, 2021
Will Remotely Based Pulmonary Rehabilitation Water Down Its Effectiveness?Himanshu Rawal, Sharon D Cornelison, Sheryl M Flynn, et al.
BMC Family Practice|June 5, 2016
A retrospective study of two populations to test a simple rule for spirometryJill A Ohar, Barbara P Yawn, Gregg L Ruppel, et al.
Annals of the American Thoracic Society|April 14, 2017
Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause ReadmissionsChee H Loh, Stephen P Peters, Tina M Lovings, et al.
Respiratory Medicine|August 22, 2006
Identification of a mesothelioma phenotypeJill A Ohar, Elizabeth J Ampleford, Suzanne E Howard, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 5, 2016
Dual therapy strategies for COPD: the scientific rationale for LAMA + LABAJoshua S Cohen, Matthew C Miles, James F Donohue, et al.
Pulmonary Medicine|April 5, 2021
The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol DeviceDonald P Tashkin, Jill A Ohar, Arkady Koltun, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Chronic Obstructive Pulmonary Disease|December 16, 2024
COPD and Immune Checkpoint Inhibitors for Cancer: A Literature ReviewThomas W Lycan, Dustin L Norton, Jill A Ohar
Pulmonary Therapy|August 19, 2020
In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®Jill A Ohar, Andrea Bauer, Sanjay Sharma, et al.
Annals of the American Thoracic Society|March 15, 2016
Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United StatesSuchit Kumbhare, Roy Pleasants, Jill A Ohar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2020
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized GlycopyrrolateJill A Ohar, Ayca Ozol-Godfrey, Thomas Goodin, et al.
Life (Basel, Switzerland)|November 27, 2021
Will Remotely Based Pulmonary Rehabilitation Water Down Its Effectiveness?Himanshu Rawal, Sharon D Cornelison, Sheryl M Flynn, et al.
BMC Family Practice|June 5, 2016
A retrospective study of two populations to test a simple rule for spirometryJill A Ohar, Barbara P Yawn, Gregg L Ruppel, et al.
Annals of the American Thoracic Society|April 14, 2017
Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause ReadmissionsChee H Loh, Stephen P Peters, Tina M Lovings, et al.
Respiratory Medicine|August 22, 2006
Identification of a mesothelioma phenotypeJill A Ohar, Elizabeth J Ampleford, Suzanne E Howard, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 5, 2016
Dual therapy strategies for COPD: the scientific rationale for LAMA + LABAJoshua S Cohen, Matthew C Miles, James F Donohue, et al.
Pulmonary Medicine|April 5, 2021
The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol DeviceDonald P Tashkin, Jill A Ohar, Arkady Koltun, et al.
Pageof 6